Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
A common gut microbe secretes a carcinogen
Cancer mutations can be caused by common gut bacteria carried by many people. This was…
Study reveals potential new treatment for patients with metastatic melanoma
Researchers at the University of Cincinnati, USA, have uncovered a potentially more beneficial treatment regimen…
Researchers announce progress in developing an accurate, noninvasive urine test for prostate cancer
Researchers at the Johns Hopkins Kimmel Cancer Center in the US have made significant progress…
Survivorship challenges for Australian women with breast cancer
By Michelle Marven. “Some days I feel more anxious and less confident about my future than I did when I was…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.